Naglaa Shehab | Drug Discovery and Development | Editorial Board Member

Published on by Top Pharmaceutical

Editorial Board Member

Naglaa Shehab — Dubai Medical University
Naglaa Shehab
Affiliation Dubai Medical University
Country United Arab Emirates
Scopus ID 26424069600
Documents 446
Citations 494
h-index 13
Subject Area Drug Discovery and Development
Event International Top Pharmaceutical Awards
ORCID 0000-0002-7514-4055

Naglaa Shehab is recognized for her academic and scientific contributions in pharmaceutical sciences, pharmacognosy, medicinal plant research, and drug discovery investigations. Her scholarly activities demonstrate continuous engagement in phytochemical analysis, natural product development, biological activity assessment, and interdisciplinary pharmaceutical research. Through her editorial and academic involvement at Dubai Medical University, she has contributed to advancing research standards and scientific communication within pharmaceutical sciences.[1] Her work reflects sustained participation in pharmacological innovation, natural medicine evaluation, and translational pharmaceutical studies with relevance to both academic and clinical applications.[2]

Abstract

This academic article presents a structured overview of the editorial and scientific profile of Naglaa Shehab within the field of pharmaceutical sciences. The profile highlights her contributions to pharmacognosy, medicinal plant research, phytochemical investigations, drug-herb interaction studies, and pharmaceutical development. Her research activities demonstrate interdisciplinary collaboration across pharmaceutical chemistry, biological evaluation, and natural product therapeutics. The article additionally reviews selected scientific publications, citation indicators, institutional affiliations, and academic contributions associated with pharmaceutical innovation and evidence-based natural medicine investigations.[1]

Keywords

Pharmacognosy, Drug Discovery, Medicinal Plants, Pharmaceutical Sciences, Natural Products, Phytochemical Investigation, Drug Development, Pharmaceutical Research, Herbal Medicine, Biological Activities

Introduction

Research in pharmaceutical sciences increasingly integrates natural product chemistry, biological evaluation, and translational therapeutic development. Naglaa Shehab has contributed to this multidisciplinary area through research involving medicinal plants, phytochemical profiling, anticancer evaluation, antioxidant studies, and pharmaceutical formulations. Her scientific work spans multiple domains including pharmacognosy, pharmaceutical chemistry, and drug interaction investigations. These activities support broader efforts to identify bioactive compounds and therapeutic applications relevant to healthcare and pharmaceutical innovation.[3]

Research Profile

Naglaa Shehab serves within the academic environment of Dubai Medical University and maintains active involvement in pharmaceutical sciences education and research. Her profile reflects long-term experience in pharmacognosy, medicinal plant analysis, extraction methodologies, and phytochemical characterization. Academic responsibilities have included curriculum development, faculty activities, research coordination, and scientific mentoring. Research interests include herbal-drug interactions, biological evaluation of natural compounds, pharmaceutical formulations, and investigation of medicinal plant constituents with potential therapeutic applications.[1]

  • Research specialization in pharmacognosy and natural products
  • Experience in medicinal plant extraction and phytochemical analysis
  • Editorial and academic participation in pharmaceutical sciences
  • Focus on biological activity evaluation and drug development research

Research Contributions

The research contributions associated with Naglaa Shehab include investigations into anticancer activity, antioxidant mechanisms, hepatoprotective effects, pharmaceutical nanocarriers, herbal formulations, and phytotherapeutic interventions. Her work has examined medicinal plant extracts and their applications in pharmaceutical formulations intended for therapeutic evaluation. Several studies have explored cancer-related mechanisms, drug safety, inflammatory modulation, and natural compounds with potential pharmacological significance.[2][4]

  • Development of phytochemical and natural product formulations
  • Evaluation of anticancer and antioxidant activities
  • Research on medicinal plant-derived therapeutic compounds
  • Studies addressing pharmaceutical efficacy and biological mechanisms

Publications

The publication record of Naglaa Shehab primarily focuses on pharmacognosy, medicinal plants, phytochemical investigations, pharmaceutical formulations, and biological activity evaluation of natural compounds. Her studies commonly explore anticancer activity, antioxidant mechanisms, herbal therapeutics, drug-herb interactions, and pharmaceutical applications of plant-derived bioactive substances. Several publications investigate the therapeutic potential of medicinal extracts through experimental and pharmaceutical approaches, particularly in cancer treatment, inflammatory disorders, hepatoprotective activity, and pharmaceutical nanocarrier systems. The research profile also demonstrates continued involvement in interdisciplinary pharmaceutical sciences and evidence-based natural product development.[3][4]

Research Impact

The research profile of Naglaa Shehab demonstrates measurable scholarly engagement through indexed publications, citation activity, and interdisciplinary pharmaceutical investigations. Her scientific output has addressed medicinal chemistry, herbal medicine, oncology-related pharmaceutical research, and biological evaluation of natural compounds. The documented h-index and citation metrics indicate ongoing academic visibility within pharmaceutical and pharmacognosy-related research communities.[1][5]

Award Suitability

Naglaa Shehab demonstrates suitability for recognition within pharmaceutical and biomedical academic platforms due to her contributions to drug discovery, pharmacognosy, medicinal plant investigations, and pharmaceutical sciences education. Her participation in scientific publishing, interdisciplinary collaborations, and research development aligns with the objectives of international pharmaceutical recognition initiatives. The combination of research productivity, editorial engagement, and pharmaceutical innovation supports her relevance to academic award and editorial board recognition programs.[5]

Conclusion

The academic profile of Naglaa Shehab reflects continued engagement in pharmaceutical sciences, medicinal plant investigations, and natural product research. Her scholarly contributions encompass pharmaceutical formulations, phytochemical analysis, biological evaluation, and interdisciplinary healthcare applications. Through editorial participation, scientific publications, and pharmaceutical research activities, she contributes to ongoing developments within drug discovery and pharmaceutical innovation.[1][2]

References

  1. ORCID. (2026). Naglaa Shehab ORCID profile and academic activities. ORCID Registry.https://orcid.org/0000-0002-7514-4055
  2. Elsevier. (n.d.). Scopus author details: Naglaa Shehab, Author ID 26424069600. Scopus.https://www.scopus.com/authid/detail.uri?authorId=26424069600
  3. Khalifa, A., Shehab, N.G., et al. (2026). Development of Phyllanthus emblica Extract-Loaded Niosomes for Cancer Treatment: Formulation and In Vitro Evaluation. Pharmaceuticals.DOI:https://doi.org/10.3390/ph19040582
  4. Bou Malhab, L.J., Shehab, N.G., et al. (2023). Potential Anticancer Properties of Calotropis procera: An Investigation on Breast and Colon Cancer Cells. Heliyon.DOI:https://doi.org/10.1016/j.heliyon.2023.e16706
  5. Anbar, H.S., El Wakil, A., Shehab, N.G., et al. (2024). The wound healing and hypoglycemic activates of date palm (Phoenix dactylifera) leaf extract and saponins in diabetic and normal rats. PLOS ONE.
    DOI: https://doi.org/10.1371/journal.pone.0308879

Walter Manucha | Nanopharmacology | Best Researcher Award

Published on by Top Pharmaceutical

Best Researcher Award

Walter Manucha
National Scientific and Technical Research Council, Argentina
Walter Manucha
Affiliation National Scientific and Technical Research Council
Country Argentina
Scopus ID 57195218813
Documents 2665
Citations 3316
h-index 34
Subject Area Nanopharmacology
Event International Top Pharmaceutical Awards
ORCID 0000-0002-2279-7626

Walter Manucha is a researcher affiliated with the National Scientific and Technical Research Council in Argentina, with academic contributions associated with nanopharmacology, biomedical sciences, and translational therapeutic research. His scholarly profile reflects extensive publication activity, interdisciplinary scientific collaboration, and measurable citation performance within international indexing systems.[1] The recognition associated with the Best Researcher Award acknowledges sustained research productivity, scientific influence, and contributions to pharmaceutical and biomedical advancement within an international academic framework.[2]

Abstract

The Best Researcher Award article documents the academic profile and research standing of Walter Manucha in the field of nanopharmacology and pharmaceutical sciences. The article summarizes publication metrics, scholarly influence, interdisciplinary contributions, and international research visibility indexed through global academic databases.[1] It also evaluates the researcher’s suitability for recognition under the International Top Pharmaceutical Awards framework, emphasizing scientific productivity, citation impact, and contributions to biomedical innovation.[2]

Keywords

Nanopharmacology, Pharmaceutical Sciences, Biomedical Research, Drug Delivery, Translational Medicine, Scopus Metrics, Scientific Impact, Research Excellence, International Awards, Academic Recognition

Introduction

Academic recognition programs in pharmaceutical sciences frequently evaluate candidates using publication performance, citation analysis, interdisciplinary collaboration, and international scientific influence. Walter Manucha’s research activities are associated with nanopharmacology and therapeutic innovation, areas that continue to contribute to modern biomedical and pharmaceutical development.[1] Through indexed scholarly publications and measurable citation metrics, the researcher demonstrates sustained participation in peer-reviewed scientific advancement and international academic communication.[3]

Research Profile

Walter Manucha is affiliated with the National Scientific and Technical Research Council in Argentina and has developed a research profile connected to nanopharmacology, pharmaceutical sciences, and biomedical investigation. The Scopus-indexed profile records substantial publication activity and measurable scholarly visibility through citations and h-index indicators.[1] His academic contributions demonstrate participation in multidisciplinary scientific collaboration and translational research themes relevant to therapeutic sciences and clinical innovation.[4]

  • Institutional affiliation with the National Scientific and Technical Research Council.
  • Research specialization associated with nanopharmacology and biomedical sciences.
  • Scopus-indexed publication and citation visibility.
  • International academic dissemination and interdisciplinary collaboration.

Research Contributions

The researcher’s scientific activities contribute to areas related to drug development, therapeutic mechanisms, biomedical applications, and pharmaceutical innovation. Nanopharmacology represents an emerging interdisciplinary field integrating nanotechnology with pharmacological sciences to improve targeted therapeutic approaches and biomedical efficiency.[4] The research output associated with Walter Manucha reflects scholarly engagement with evolving pharmaceutical technologies and evidence-based biomedical methodologies.[5]

  • Development of interdisciplinary biomedical research frameworks.
  • Contributions to therapeutic and pharmaceutical sciences.
  • Scientific dissemination through indexed journal publications.
  • Participation in internationally recognized research communication platforms.

Publications

The publication record associated with Walter Manucha reflects extensive participation in scholarly communication and indexed scientific literature. Indexed databases identify numerous publications linked to pharmaceutical sciences and biomedical research themes.[1] Publication visibility and citation engagement indicate active dissemination within the international scientific community.[3]

  1. Research articles in nanopharmacology and biomedical sciences.
  2. Peer-reviewed publications indexed in international databases.
  3. Collaborative scientific contributions in pharmaceutical research.
  4. Publications contributing to translational and therapeutic innovation.

Research Impact

Research impact indicators demonstrate measurable academic visibility through citation performance, indexed publications, and h-index evaluation. Citation activity associated with the researcher indicates that published works have contributed to ongoing scientific discussion and scholarly reference within related biomedical domains.[1] The h-index score further reflects sustained research productivity and academic engagement over time.[3]

  • Scopus-indexed visibility and citation accumulation.
  • Sustained publication activity within pharmaceutical sciences.
  • Research dissemination through international scholarly networks.
  • Academic influence reflected through measurable bibliometric indicators.

Award Suitability

The Best Researcher Award recognizes sustained scientific contribution, publication excellence, and measurable academic impact within pharmaceutical and biomedical sciences. Walter Manucha’s documented research metrics, publication record, and interdisciplinary scientific involvement demonstrate alignment with the evaluative principles commonly associated with international academic recognition programs.[2] The researcher’s profile indicates scholarly consistency, international indexing visibility, and participation in evidence-based scientific advancement relevant to nanopharmacology and translational biomedical research.[5]

Conclusion

Walter Manucha’s academic profile reflects sustained scientific productivity, interdisciplinary collaboration, and measurable scholarly visibility within pharmaceutical and biomedical sciences. Through indexed publications, citation performance, and contributions associated with nanopharmacology, the researcher demonstrates continued engagement with internationally recognized scientific research activities.[1] The documented academic metrics and research dissemination support recognition under the Best Researcher Award category within the International Top Pharmaceutical Awards framework.[2]

References

  1. Elsevier. (n.d.). Scopus author details: Walter Manucha, Author ID 57195218813. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57195218813
  2. International Top Pharmaceutical Awards. (n.d.). Academic recognition and pharmaceutical research excellence platform.
    https://toppharmaceutical.org/
  3. Martín Gimenez, V. M., García Menendez, S., & Manucha, W. (2026). Multi-endogenous nanoformulation for endocannabinoid and hormonal modulation of key signaling pathways in resistant hypertension. Current Pharmaceutical Design.
    https://doi.org/10.2174/0113816128396666250728074858
  4. Reiter, R. J., Sharma, R., Loh, D., Chuffa, L. G. A., Bai, Y., Zuccari, D. A. P. C., Galano, A., & Manucha, W. (2026). Melatonin targets mitochondrial redox homeostasis: Optimizing the intracellular microenvironment. International Journal of Molecular Sciences.
    https://doi.org/10.3390/ijms27104496
  5. Carloni, S., Luchetti, F., Nasoni, M. G., Balduini, W., Manucha, W., & Reiter, R. J. (2026). Melatonin and mitochondrial stress: New insights into age-related neurodegeneration. Neural Regeneration Research.
    https://doi.org/10.4103/NRR.NRR-D-24-01380

Chattar Singh Yadav | Pharmaceutical Manufacturing | Pharmaceutical Excellence Award 

Published on by Top Pharmaceutical

Dr. Chattar Singh Yadav | Pharmaceutical Manufacturing | Pharmaceutical Excellence Award

Senior Manager | Aurobindo Pharma Limited | India

Dr. Chattar Singh Yadav is a researcher at Aurobindo Pharma, India, specializing in pharmaceutical sciences with a focus on applied research and drug development. He holds advanced academic training in pharmaceutical disciplines, with specialization in areas aligned to pharmacological and formulation sciences. His professional experience includes contributions to industry-oriented research projects, supporting the development and evaluation of pharmaceutical products while demonstrating active involvement in collaborative and technical roles. His research focus encompasses formulation strategies, drug analysis, and applied pharmacokinetics, reflected in a growing body of publications and measurable citation impact. Dr. Yadav’s work contributes to the advancement of practical and scalable solutions in the pharmaceutical domain. He has received recognition for his research contributions through citation-based metrics and continues to build his academic profile through ongoing research engagement. He is also associated with scholarly activities, contributing to the scientific community through research dissemination and professional participation, indicating strong potential for future impact and leadership in pharmaceutical research.

Citation Metrics (Google Scholar)

39
30
20
10
0

39

2

1

Citations

h-index

i10-index


Featured Publications

 

SILVIA MARIA DÍAZ PRADO | Drug Delivery Systems | Lifetime achievement Award

Published on by Top Pharmaceutical

SILVIA MARIA DÍAZ PRADO | Drug Delivery Systems | Lifetime achievement Award

Prof. Dr. SILVIA MARIA DÍAZ PRADO, University of A Coruña, Spain

Prof. Dr. Silvia María Díaz Prado is a Professor of Anatomy at the University of A Coruña and leads the Cellular Therapy and Regenerative Medicine Group at INIBIC. With a PhD in Biology (2004), her research spans tissue engineering, stem cells 🧬 (including iPSCs), novel biomaterials, 3D bioprinting 🖨️, and nanoparticle drug delivery 💊. She has published 68 articles (H-index: 24), 32 book chapters, and presented at 215 conferences. Dr. Díaz Prado has led 33 research projects, supervised over 50 theses, and received 7 research awards 🏅. She coordinates the Master’s in Health Care and Research program.

Publication Profile

Google Scholar

Education

Prof. Dr. Silvia María Díaz Prado 🎓 holds a Ph.D. in Biology (2004) from the University of A Coruña, where she serves as a Professor of Anatomy 🧠 and coordinates the Master’s Degree in Health Care and Research 💉📚. With a distinguished academic career, she has played a pivotal role in shaping advanced medical education and fostering scientific inquiry 🔬. Her dedication to teaching and mentorship has inspired countless students and researchers, reinforcing her status as a respected leader in the biomedical field 🌟. Prof. Dr. Díaz Prado continues to advance excellence in health sciences through education and innovation.

Awards

Prof. Dr. Silvia María Díaz Prado 🏅 has been honored with seven prestigious research awards 🧪, reflecting the high regard in which her scientific contributions are held by the academic community 🌍. These accolades underscore her exceptional merit, dedication to innovation, and impactful work in the field of biomedical research 🧬. Each award stands as a testament to her relentless pursuit of knowledge, excellence, and advancement in science 🔍✨. Prof. Díaz Prado’s achievements not only bring recognition to her individual efforts but also elevate the institutions and research teams she represents, inspiring future generations of scientists 🎓🌟.

Research Focus

Prof. Dr. Silvia María Díaz-Prado is a distinguished researcher in the field of Regenerative Medicine 🧬🦴, with a strong focus on stem cells, cartilage repair, and molecular signaling in musculoskeletal disorders. Her groundbreaking work explores microRNA profiling🧪, mesenchymal stem cells🧫, and the human amniotic membrane as a novel source for cell therapy. She also investigates oncogenic pathways like Wnt, Notch, and Hedgehog 🔬, linking them to cancer stem cells. Prof. Díaz-Prado’s contributions bridge molecular biology with clinical applications, making her a key figure in orthopedic tissue engineering, biomarkers, and cell-based therapeutic strategies.

Publication Top Notes

Characterization of microRNA expression profiles in normal and osteoarthritic human chondrocytes

Cloning genes from a library using a clustering strategy and PCR

Multilineage differentiation potential of cells isolated from the human amniotic membrane

Human amniotic membrane as an alternative source of stem cells for regenerative medicine

Wnt signalling and cancer stem cells

Notch signalling in cancer stem cells

Potential use of the human amniotic membrane as a scaffold in human articular cartilage repair

Quantification of cells expressing mesenchymal stem cell markers in healthy and osteoarthritic synovial membranes

Effects of severe hypoxia on bone marrow mesenchymal stem cells differentiation potential

Cyclooxygenase-2 (COX-2): a molecular target in prostate cancer

Isolation and characterization of mesenchymal stem cells from human amniotic membrane

Induced pluripotent stem cells for cartilage repair: current status and future perspectives

Biology of BMP signalling and cancer

Oliwia Kordyl | Drug Delivery Systems | Best Research Article Award

Published on by Top Pharmaceutical

Oliwia Kordyl | Drug Delivery Systems | Best Research Article Award

Ms. Oliwia Kordyl, Poznan Univeristy of Medical Sciences, Poland

Ms. Oliwia Kordyl (b. June 9, 1997) is a dedicated PhD student at Poznan University of Medical Sciences, specializing in 3D printed microneedles for targeted drug delivery. With a background in biotechnology from Adam Mickiewicz University, her work spans molecular biology, pharmaceutical technology, and reproductive genetics. Oliwia has held roles as a lab manager, molecular biologist, and biotechnologist, contributing to innovative projects and scientific conferences. She is skilled in advanced lab techniques and passionate about travel, fitness, and continuous learning.

Publication Profile

orcid

Education

Ms. Oliwia Kordyl is currently pursuing her Ph.D. (Nov 2023–Present) at the Poznan University of Medical Sciences in Poland, focusing on 3D printed microneedles for voriconazole delivery in treating local skin infections. Her research involves optimizing microneedle manufacturing, assessing physicochemical and pharmaceutical properties in vitro, and evaluating drug permeation ex vivo and microbiological effectiveness 🧪🧬. She earned her M.Sc. and B.Sc. in biotechnology from Adam Mickiewicz University (2016–2021), where she explored DNA methylation in oligozoospermia and gene expression in spermatogenesis 🧫. Her academic journey began at K.K. Baczyński Secondary School, specializing in biology, physics, and chemistry 🔬📚.

Experience

Ms. Oliwia Kordyl completed a valuable internship at Novazym Polska in Poznań from July to August 2019. During her time at this renowned biotechnology company, she gained hands-on experience in laboratory techniques and deepened her understanding of industrial biotechnology practices 🔬💼. The internship provided her with practical insights into the daily operations of a biotech firm and allowed her to apply her academic knowledge in a real-world setting 🧪📊. This experience not only enhanced her technical skills but also strengthened her passion for research and innovation in the field of biotechnology, laying a strong foundation for her future scientific endeavors 🚀.

Awards

🏆 Ms. Oliwia Kordyl has actively contributed to the scientific community through speeches and posters at esteemed conferences. She presented on sperm DNA methylation at the 21st Andrology Day (2019) 🧬 and the 21st European Testis Workshop (2021) in Barcelona. Her posters featured at ESHRE 2020, the European Human Genetics Conference (2021), and the 6th Polish Congress of Genetics (2022) showcased her expertise in epigenetics and sperm chromatin structure 🧫📊. In 2023, she co-authored a poster on microneedles for transdermal drug delivery at PolGerSym10 💉. Oliwia also co-authored a publication in the International Journal of Molecular Sciences (2022) 📄📚.

Research Focus

Ms. Oliwia Kordyl’s research focuses on the development of innovative drug delivery systems, particularly microneedle-based technologies for transdermal applications. Her work combines 3D printing, pharmaceutical coatings, and hydrogel systems to enhance the treatment of bacterial and fungal skin infections. She also explores photodynamic therapy and nanotechnology for targeted drug release. Her interdisciplinary approach bridges materials science, biomedical engineering, and pharmaceutics. Additionally, her research extends to epigenetic analysis in human sperm, highlighting her interest in reproductive biology. Her work is at the frontier of personalized medicine, non-invasive therapies, and advanced pharmaceutical technologies.

Publication Top Notes

Optimization of LCD-Based 3D Printing for the Development of Clotrimazole-Coated Microneedle Systems

Microneedle-based arrays – Breakthrough strategy for the treatment of bacterial and fungal skin infections

Microneedle System Coated with Hydrogels Containing Protoporphyrin IX for Potential Application in Pharmaceutical Technology

Global 5mC and 5hmC DNA Levels in Human Sperm Subpopulations with Differentially Protaminated Chromatin in Normo- and Oligoasthenozoospermic Males

Assoc Prof Dr. Mohammed Saddik |Formulation Science |Best Researcher Award

Published on by Top Pharmaceutical

Assoc Prof Dr. Mohammed Saddik|Formulation Science |Best Researcher Award|

Assoc Prof Dr. Mohammed Saddik atFaculty of Pharmacy, Sohag University, Egypt

PROFILE  

 

Orcid

Early Academic Pursuits 🎓

Mohammed Sherif Saddik Ibrahim began his academic journey with a strong foundation in pharmaceutical sciences. He earned his Bachelor of Pharmaceutical Sciences from the Faculty of Pharmacy, Assiut University, Egypt, on July 22, 2006. His dedication to the field was evident early on, as he quickly advanced to pursue postgraduate studies. By July 24, 2011, he had obtained his Master’s degree in Pharmaceutical Sciences, specializing in pharmaceutics. His master’s thesis, titled “Formulation and Clinical Evaluation of Some Topical Pharmaceutical Dosage Forms of Phenytoin,” highlighted his interest in the clinical applications of pharmaceuticals. Not stopping there, Mohammed continued his academic pursuits, earning a Doctor of Pharmaceutical Sciences (Ph.D.) in Pharmaceutics from Assiut University on January 24, 2017. His doctoral research focused on the “Formulation and Clinical Evaluation of Some Topical Pharmaceutical Dosage Forms of Methylene Blue for Photodynamic Therapy,” showcasing his commitment to innovative therapeutic solutions.

Professional Endeavors 🧑‍🏫

Dr. Mohammed Sherif Saddik Ibrahim’s professional career is marked by his continuous advancement in academia and clinical practice. He began as a Pharmacist at Al-Azhar University Hospital, Faculty of Medicine, Assiut University, where he worked from July 24, 2007, to October 11, 2014. This role allowed him to gain practical experience in the pharmaceutical field, which he later integrated into his teaching and research.

In 2014, Mohammed transitioned to an academic role at Sohag University, Egypt, where he served as an Assistant Lecturer of Pharmaceutics and Clinical Pharmacy until February 26, 2017. Following his Ph.D., he was promoted to Lecturer in the same department, a position he held until June 27, 2022. His excellence in teaching and research led to his appointment as an Associate Professor of Pharmaceutics and Clinical Pharmacy at Sohag University on June 29, 2022, where he continues to contribute to the field. Additionally, since September 13, 2022, Mohammed has been coordinating the Clinical Pharmacy Program at Sohag University, further cementing his role as a leader in pharmacy education.

Contributions and Research Focus 💡

Dr. Mohammed Sherif Saddik Ibrahim’s research is centered around the formulation and clinical evaluation of pharmaceutical dosage forms. His work has significant implications for enhancing the therapeutic efficacy of drugs and improving patient outcomes. One of his notable research contributions includes the development of topical pharmaceutical dosage forms for photodynamic therapy, specifically using methylene blue. This research is particularly important for its potential in treating various skin conditions and diseases through non-invasive methods.

Mohammed’s innovative approach is also evident in his work on drug delivery systems. He has supervised multiple postgraduate students, guiding them in research that explores novel drug formulations and delivery methods. His expertise in handling lab animals and conducting clinical studies further supports his research goals, particularly in designing dosage forms that are both effective and patient-friendly.

Accolades and Recognition 🏆

Throughout his career, Dr. Mohammed Sherif Saddik Ibrahim has received recognition for his contributions to pharmaceutical sciences. His work has led to several patents, including those for sulfasalazine-loaded zinc oxide nanoparticles for the treatment of ulcerative colitis (US11730759B1) and a polymeric clotrimazole biofilm for the treatment of otomycosis (US11844781B1). These patents reflect his innovative thinking and commitment to developing new therapeutic solutions.

His academic contributions have also been recognized through his participation in significant conferences. Notably, he presented at the NUB 2nd Conference of Scientific Research in Pharmacy Future Insight at the Faculty of Pharmacy, Nahda University, in March 2019, and the 1st Conference of Pharmaceutical Sciences at Badr University in Cairo, held online in November 2021. These platforms allowed him to share his research findings with the broader scientific community and gain insights into the latest developments in pharmaceutical sciences.

Impact and Influence 🌍

Dr. Mohammed Sherif Saddik Ibrahim’s impact on the field of pharmaceutics extends beyond his research. As an educator, he has taught a wide range of courses at Sohag University, including Pharmaceutics, Physical Pharmacy, Community Pharmacy, Controlled Drug Delivery, and Pharmaceutical Legislations & Regulatory Affairs. His teaching not only imparts knowledge but also inspires the next generation of pharmacists and researchers. Mohammed’s role as a coordinator of the Clinical Pharmacy Program at Sohag University further amplifies his influence, as he shapes the curriculum and ensures that students receive a comprehensive and up-to-date education.

His contributions to research have also had a tangible impact on patient care. The dosage forms and drug delivery systems he has developed have the potential to improve the treatment of various conditions, from skin diseases to chronic illnesses like ulcerative colitis. By focusing on patient-centered research, Mohammed’s work is helping to bridge the gap between laboratory research and clinical practice, ultimately benefiting patients in Egypt and beyond.

Legacy and Future Contributions 🚀

As a progressive professional with a strong research background, Dr. Mohammed Sherif Saddik Ibrahim is poised to continue making significant contributions to the field of pharmaceutical sciences. His commitment to education and research, particularly in the area of drug delivery systems, positions him as a leader in the field. Looking ahead, Mohammed aims to further explore the green synthesis of nanomaterials and their application in drug delivery. His goal is to develop innovative pharmaceutical dosage forms that are not only effective but also environmentally sustainable.

Mohammed’s vision for the future includes expanding his research to address emerging medical challenges, such as diabetes and leukemia. With two patents already in progress for treatments in these areas, he is actively working towards solutions that could have a profound impact on global health. His determination to identify innovative approaches and improve medical outcomes drives his research and teaching efforts.

Conclusion 🌟

Dr. Mohammed Sherif Saddik Ibrahim’s career is a testament to his dedication to advancing pharmaceutical sciences. From his early academic pursuits to his current role as an Associate Professor and researcher, he has consistently sought to improve drug delivery systems and therapeutic efficacy. His contributions to education, research, and patient care have left a lasting impact, and his future work promises to bring even more innovative solutions to the field. As he continues to explore new frontiers in pharmaceutics, Mohammed’s legacy as a visionary educator and researcher will undoubtedly grow.

🎓Publication 

Formulation and evaluation of azithromycin-loaded silver nanoparticles for the treatment of infected wounds.

  • Authors   :Saddik MS; Al-Hakkani MF; Abu-Dief AM; Mohamed MS; Al-Fattah IA; Mahmoud Makki; El-Mokhtar MA; Marwa A. Sabet; Amin MS; Ahmed HA et al...
  • Journal    :pharmaceutics
  • Year         :2024

Characterization and Bio-Evaluation of the Synergistic Effect of Simvastatin and Folic Acid as Wound Dressings on the Healing Process

  • Authors   : Mahmoud A. Hashem; Badriyah S. Alotaibi; Mahmoud M.A. Elsayed; Manal E. Alosaimi; Amal K. Hussein; Maram Abduljabbar; Kyung-Tae Lee; Hamdy Abdelkader; Mohamed A. El-Mokhtar ; Ahmed Hassan et al.
  • Journal    :Pharmaceutics
  • Year         :2023

Synthesis, Physicochemical Characterization using a Facile Validated HPLC Quantitation Analysis Method of 4-Chloro-phenylcarbamoyl-methyl Ciprofloxacin and Its Biological Investigations

  • Authors   :Mostafa F. Al-Hakkani; Nourhan Ahmed; Alaa A. Abbas; Mohammad H. A. Hassan; Hossameldin A. Aziz; Ali M. Elshamsy; Hazim O. Khalifa; Mohamed A. Abdelshakour; Mohammed S. Saddik; Mahmoud M. A. Elsayed et al.
  • Journal    :Molecular Sciences
  • Year         :2023

Development of Novel Nano-Sized Imine Complexes Using Coriandrum sativum Extract: Structural Elucidation, Non-Isothermal Kinetic Study, Theoretical Investigation and Pharmaceutical Applications

  • Authors   : Shimaa Hosny; Randa F. Abd El-Baki; Zeinab H. Abd El-Wahab; Gamal A. Gouda; Mohammed S. Saddik; Ateyatallah Aljuhani; Ahmed M. Abu-Dief.
  • Journal    :Molecular Sciences
  • Year         :2023

In vitro and in vivo synergistic wound healing and anti-methicillin-resistant Staphylococcus aureus (MRSA) evaluation of liquorice-decorated silver nanoparticles

  • Authors   :Hamdoon Mohammed; Mohammed A. Amin; Gamal Zayed; Yassar Hassan; Mohamed El-Mokhtar; Mohammed S. Saddik..
  • Journal    : Antibiotics
  • Year         :2023

Dr.Alice Bejjan| Pharmaceutical Analysis| Women Researcher Award

Published on by Top Pharmaceutical

Dr.Alice Bejjan,Pharmaceutical Analysis ,Women Researcher Award

Dr.Alice Bejjan, at ational Council for Scientific Research of Lebanon-Lebanese Atomic Energy Commission, Lebanon

 Profiles

Scopus

Google scholar         

Orcid

🎓Early Academic Pursuits :

Alice Bejjani’s journey into the world of physics began with a solid academic foundation. She pursued her undergraduate studies at the Lebanese University, Department of Physics and Electronics in Fanar, Lebanon, where she earned her Maitrise in Physics with high distinction in 2003. Her passion for materials science and electronic components led her to continue her studies at the Lebanese University, Faculty of Sciences. There, she obtained a Master of Advanced Studies (DEA) in 2004, once again graduating with high distinction. Alice’s academic pursuits culminated in a Ph.D. in Physics from the Claude Bernard University of Lyon, Institute of Nuclear Physics, France, in 2009, where she achieved the highest honors.

🏢Professional Endeavors :

Alice’s professional career is marked by her extensive contributions to the Lebanese Atomic Energy Commission-National Council for Scientific Research (LAEC-NCSR). She began her journey as a part-time research assistant at the Accelerator Laboratory of LAEC-NCSR in 2004-2005. Following her Ph.D., she returned to LAEC-NCSR as a part-time researcher, equivalent to a post-doctoral position, from 2010 to 2014. During this time, she played a pivotal role in establishing the first research laboratory in the MENA region for surface, chemical, and structural analysis of solid materials using the Time of Flight Secondary Ion Mass Spectrometry (TOF-SIMS) technique.

In 2014, Alice was appointed as a full-time researcher at LAEC-NCSR, a position she held until 2019. Her research interests include exploring novel applications, developing innovative protocols, and combining ion beam technology with optical spectroscopic and chromatography methods to examine materials pertinent to health, environmental studies, and forensic sciences. Since 2019, she has been serving as a senior researcher, furthering her contributions to the field.

🔬Contributions and Research Focus :

Alice’s research has had a profound impact on the fields of health, environmental studies, and forensic sciences. As the coordinator of the Forensic Research Program at LAEC-NCSR since 2016, she has fostered synergy among her fellow researchers to achieve program objectives. She has designed and implemented Memorandums of Understanding (MOUs) with partners, driving impactful advancements in forensic research.

As the principal investigator of the TOF-SIMS laboratory, Alice oversees a team of researchers, research assistants, and master’s/Ph.D. students. She has established and enforced standard operating protocols to ensure compliance with safety and regulatory guidelines, maintained the laboratory’s cutting-edge status through equipment procurement and technology advancements, and implemented preventive maintenance plans to ensure optimal functionality and efficiency. Her efforts have also included fostering collaborations with local and international universities and research centers.

 🏆Accolades and Recognition :

Alice’s dedication and contributions to science have been recognized through various national and international grants. Notable among these are:

  1. TC-IAEA Grant (2022-2025): €405,000 for strengthening forensic needs in material investigation.
  2. NCSR National Grant (2018-2019): $19,000 for multi-dimensional analysis of new functional polymers.
  3. NCR Italy-NCSR Mobility Grant (2017-2019): €8,000 for safeguarding saffron authenticity using innovative mass spectrometry.
  4. TC-IAEA Grant (2015-2018): €350,000 for enhancing forensic science capabilities.
  5. TC-IAEA Grant (2012-2014): €350,000 for upgrading surface, elemental, and structural analysis capabilities.
  6. TC-IAEA Grant (2010-2012): €522,000 for enhancing the LAEC’s analytical capabilities.

🌟Impact and Influence :

Alice’s work has had a significant impact on the scientific community and beyond. Her research has contributed to advancements in forensic science, health, and environmental studies. By developing innovative protocols and combining ion beam technology with other analytical methods, she has opened new avenues for material analysis. Her leadership in establishing and maintaining the TOF-SIMS laboratory has provided valuable resources for researchers in the MENA region and internationally.

🌍Legacy and Future Contributions :

Alice Bejjani’s legacy is one of dedication, innovation, and collaboration. Her contributions to the scientific community, particularly in the fields of forensic science and material analysis, have set a high standard for future researchers. As she continues her work at LAEC-NCSR, she is poised to make further advancements in her field, fostering interdisciplinary collaboration and driving impactful research. Her commitment to mentoring the next generation of scientists ensures that her influence will continue to be felt for years to come. Alice’s journey is a testament to the power of perseverance, passion, and the pursuit of excellence in science.

🎓Publication 

Fe0-based trimetallic systems for the removal of aqueous diclofenac: Mechanism and kinetics

  • Authors   :Antoine Ghauch, Hala Abou Assi, Habib Baydoun, Al Muthanna Tuqan, Alice Bejjani
  • Journal    :Chemical Engineering Journal
  • Year         : 2011

Iron-based metal organic framework MIL-88-A for the degradation of naproxen in water through persulfate activation

    • Authors : Rime El Asmar, Abbas Baalbaki, Zahraa Abou Khalil, Sahar Naim, Alice Bejjani, Antoine Ghauch
    • Journal   :Chemical Engineering Journal
    • Year       : 2011
Toward cell selective surfaces: cell adhesion and proliferation on breath figures with antifouling surface chemistry
  • Authors  : Enrique Martínez-Campos, Tamara Elzein, Alice Bejjani, Maria Jesús García-Granda, Ana Santos-Coquillat, Viviana Ramos, Alexandra Muñoz-Bonilla, Juan Rodríguez-Hernández
  • Journal    :ACS Applied Materials & Interfaces
  • Year         :  2016
Hydrophobization of chitosan films by surface grafting with fluorinated polymer brushes
  • Authors  : Bénédicte Lepoittevin, Tamara Elzein, Diana Dragoe, Alice Bejjani, Frédéric Lemée, Jocelyne Levillain, Philippe Bazin, Philippe Roger, Isabelle Dez
  • Journal   :Carbohydrate polymers
  • Year        :   2019

Surface initiated supplemental activator and reducing agent atom transfer radical polymerization (SI-SARA-ATRP) of 4-vinylpyridine on poly (ethylene terephthalate)

  • Authors  : Mohamad Maaz, Tamara Elzein, Alice Bejjani, Nadine Barroca-Aubry, Bénédicte Lepoittevin, Diana Dragoe, Sandra Mazerat, Bilal Nsouli, Philippe Roger
  • Journal   :Journal of colloid and interface science
  • Year        : 2017